Publication Name	World Journal of Biological Chemistry
Manuscript ID	74322
Country	Greece

Received	2021-12-20 19:00
Peer-Review Started	2021-12-20 19:02
To Make the First Decision
Return for Revision	2022-02-21 08:38
Revised	2022-02-28 10:46
Second Decision	2022-04-22 02:15
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-04-22 19:14
Articles in Press	2022-04-22 19:14
Publication Fee Transferred
Edit the Manuscript by Language Editor	2022-04-18 04:51
Typeset the Manuscript	2022-04-27 08:44
Publish the Manuscript Online	2022-05-25 13:12

ISSN	1949-8454 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Minireviews
Article Title	Progesterone in gender-affirming therapy of trans women
Manuscript Source	Invited Manuscript
All Author List	Charalampos Milionis, Ioannis Ilias and Eftychia Koukkou
ORCID	Author(s) ORCID Number Charalampos Milionis http://orcid.org/0000-0003-2442-3772 Ioannis Ilias http://orcid.org/0000-0001-5718-7441 Eftychia Koukkou http://orcid.org/0000-0002-1433-3151
Funding Agency and Grant Number
Corresponding Author	Ioannis Ilias, MD, PhD, Consultant Physician-Scientist, Department of Endocrinology, Diabetes and Metabolism, Elena Venizelou Hospital, 2, Elena Venizelou Square, Athens GR-11521, Greece. iiliasmd@yahoo.com
Key Words	Progesterone; Transgender persons; Breast; Human; Gender dysphoria
Core Tip	The addition of bioidentical progesterone to the gender-affirming treatment of trans women may be beneficial in many ways. However, since relevant studies are lacking, further research is needed.
Publish Date	2022-05-25 13:12
Citation	Milionis C, Ilias I, Koukkou E. Progesterone in gender-affirming therapy of trans women. World J Biol Chem 2022; 13(3): 66-71
URL	https://www.wjgnet.com/1949-8454/full/v13/i3/66.htm
DOI	https://dx.doi.org/10.4331/wjbc.v13.i3.66

Full Article (PDF)	WJBC-13-66.pdf
Full Article (Word)	WJBC-13-66.docx
Manuscript File	74322_Auto_Edited-LJH_WangTQ.docx
Answering Reviewers	74322-Answering reviewers.pdf
Audio Core Tip	74322-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	74322-Conflict-of-interest statement.pdf
Copyright License Agreement	74322-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	74322-Language certificate.PDF
Peer-review Report	74322-Peer-review(s).pdf
Scientific Misconduct Check	74322-Bing-Liu JH-2.jpg
Scientific Misconduct Check	74322-CrossCheck.jpg
Scientific Editor Work List	74322-Scientific editor work list.pdf